1. Home
  2. ARQT vs HLMN Comparison

ARQT vs HLMN Comparison

Compare ARQT & HLMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARQT
  • HLMN
  • Stock Information
  • Founded
  • ARQT 2016
  • HLMN 1964
  • Country
  • ARQT United States
  • HLMN United States
  • Employees
  • ARQT N/A
  • HLMN N/A
  • Industry
  • ARQT Biotechnology: Pharmaceutical Preparations
  • HLMN Industrial Machinery/Components
  • Sector
  • ARQT Health Care
  • HLMN Consumer Discretionary
  • Exchange
  • ARQT Nasdaq
  • HLMN Nasdaq
  • Market Cap
  • ARQT 1.7B
  • HLMN 1.6B
  • IPO Year
  • ARQT 2020
  • HLMN N/A
  • Fundamental
  • Price
  • ARQT $15.00
  • HLMN $7.77
  • Analyst Decision
  • ARQT Strong Buy
  • HLMN Buy
  • Analyst Count
  • ARQT 6
  • HLMN 5
  • Target Price
  • ARQT $18.80
  • HLMN $11.25
  • AVG Volume (30 Days)
  • ARQT 2.0M
  • HLMN 1.5M
  • Earning Date
  • ARQT 08-13-2025
  • HLMN 08-05-2025
  • Dividend Yield
  • ARQT N/A
  • HLMN N/A
  • EPS Growth
  • ARQT N/A
  • HLMN N/A
  • EPS
  • ARQT N/A
  • HLMN 0.09
  • Revenue
  • ARQT $212,819,000.00
  • HLMN $1,481,633,000.00
  • Revenue This Year
  • ARQT $61.15
  • HLMN $6.41
  • Revenue Next Year
  • ARQT $37.98
  • HLMN $6.57
  • P/E Ratio
  • ARQT N/A
  • HLMN $84.80
  • Revenue Growth
  • ARQT 100.03
  • HLMN 0.31
  • 52 Week Low
  • ARQT $7.86
  • HLMN $6.55
  • 52 Week High
  • ARQT $17.75
  • HLMN $12.08
  • Technical
  • Relative Strength Index (RSI)
  • ARQT 60.23
  • HLMN 59.75
  • Support Level
  • ARQT $13.06
  • HLMN $6.75
  • Resistance Level
  • ARQT $15.36
  • HLMN $8.02
  • Average True Range (ATR)
  • ARQT 0.66
  • HLMN 0.27
  • MACD
  • ARQT 0.12
  • HLMN 0.10
  • Stochastic Oscillator
  • ARQT 82.57
  • HLMN 83.28

About ARQT Arcutis Biotherapeutics Inc.

Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population.

About HLMN Hillman Solutions Corp.

Hillman Solutions Corp is a provider of hardware-related products and related merchandising services to retail markets in North America. The company sells its products to hardware stores, home centers, mass merchants, pet supply stores, and other retail outlets. Its product lines include thousands of small parts such as fasteners and related hardware items; threaded rod and metal shapes; keys and accessories; builder's hardware; personal protective equipment, such as gloves and eye-wear; and identification items, such as tags and letters, numbers, and signs. The segments of the company are Hardware and Protective Solutions, which is the key revenue-generating segment; Robotics and Digital Solutions; and Canada. It has a business presence in the U.S., Canada and Mexico.

Share on Social Networks: